XIMED has been honored at the 2025 Bpifrance i-Lab competition, a national initiative that each year recognizes the most innovative technology startup projects in France. This major distinction highlights the scientific and clinical excellence that drives XIMED’s work in the field of medical imaging.
PhoeniX: A New Generation of Mammography Systems
At the heart of the award-winning project is PhoeniX, the groundbreaking technology developed by XIMED, introducing a true paradigm shift in breast imaging.
By leveraging X-ray phase contrast imaging within a compact, clinically integrable system, PhoeniX enables ultra-precise characterization of microcalcifications, often associated with carcinoma in situ lesions that can progress to invasive cancer if detected late.
i-Lab: A National Recognition and a Strategic Catalyst for XIMED
The i-Lab competition is a key accelerator for France’s deeptech startups.
By joining the winners of the 2025 edition, XIMED reaffirms the scientific, technological, and clinical robustness of its approach and benefits from the strategic support of the BpiFrance Deeptech label.
This application pursued a dual objective to demonstrate the scientific and clinical relevance of PhoeniX before a panel of leading experts; and to accelerate technological and industrial development toward seamless integration intro clinical practice.
A Breakthrough Innovation for Breast Cancer Diagnostics
The i-Lab jury was undoubtedly convinced by the tangible clinical impact of PhoeniX. By revealing structural details invisible to conventional imaging, the dual phase-contrast X-ray technology enables better tissue differentiation and a more reliable assessment of microcalcifications. This new generation of mammography systems aims to reduce unnecessary macrobiopsies and improve diagnostic confidence for healthcare professionals.
Building on this recognition, XIMED now plans to accelerate its R&D roadmap and strengthen partnerships with both hospitals and industry players.
The ambition: to transform PhoeniX into a certified, industrialized clinical system capable of becoming the new gold standard in mammography, in France and worldwide.
We would like to thank all our partners, shareholders, and the associations and networks XIMED is part of, as well as our entire team, for their continued support, trust and commitment : BPI France, Région Nouvelle-Aquitaine, IXCORE, IXCampus, ALPhANOV, Imagine Optic, Institut Bergonié, Laboratoire CELIA, Amplitude, Unitec, ALPHA-RLH, ALLISNA.
